Latest News

The study showed that oral semaglutide achieved a significantly greater reduction in HbA1c levels, a key marker of blood sugar control, compared to placebo.

The new Computational Innovation site will focus on using advanced data science to better understand disease biology and identify biological mechanisms with a higher likelihood of success in drug development.

The partnership aligns with Africa CDC’s Health Security and Sovereignty Agenda, which seeks to help African countries build stronger systems that can prevent, detect, and respond to disease threats while reducing reliance on external support.

The collaboration will enhance the company’s ability to analyze complex datasets, identify promising drug candidates, and significantly reduce the time required to bring medications to patients.

Under the agreement, both organizations will conduct a series of early screening campaigns across Caritas Egypt’s network of branches.

The company forecasts overall revenue growth of 2% to 4% in 2026, with operating profit projected between USD 720 million and USD 770 million.

Each nonprofit will deploy targeted interventions designed to expand point-of-care ultrasound training, strengthen referral networks, and improve outcomes for high-risk pregnancies in resource-limited settings.

Peak XV Partners leads investment round, with participation from Define Ventures and previous backers.

The Saadiyat Island clinic forms part of SEHA CLINICS’ broader expansion strategy, aligned with PureHealth’s vision to strengthen community-based healthcare across Abu Dhabi.

Programme implementation concluded on March 31, 2026, with the global initiative on track to exceed its target of reaching at least 21 million under-immunised children.